Dantrolene sodium as a possible prophylactic agent against N.M.S.
D000328:Adult; D003620:Dantrolene / Q000627:therapeutic use*; D005476:Fluphenazine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000517:prevention & control*; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy*
D003620:Dantrolene; D005476:Fluphenazine